Thiabendazole: adverse event reports in all combinations
Active ingredient, alone and in combinations
Brand names with this ingredient: Tresaderm Dermatologic, Equivet-14, Equizole-B.
The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand.
Read this first. FDA says this about the data:
An API dataset query result cannot be used to estimate the risk associated with the product or compare one drug or device product with another. When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event. This dataset should not be the sole source of information for clinical decision-making or other assumptions about the safety or effectiveness of a product. The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources.
FDA Center for Veterinary Medicine publishes these words. Source: Adverse Event Reports for Animal Drugs and Devices, read on . The data have the reports that FDA received through .
This page is not veterinary advice. For an animal that is ill, speak to a veterinarian.
Contacting a veterinarianHow to report to FDAFDA reports received through . Counts include this ingredient alone and in combinations. Why brand names have no separate count.
From January 1987 to June 2026, FDA received 2,098 adverse event reports that name a drug with thiabendazole, alone or in a combination. 3 sets of active ingredients with thiabendazole have a drug page.
Of the 2,098 reports, 813 (38.8%) are about cats. 668 reports are about dogs (31.8%). In January to March 2026, FDA received 70 reports that name thiabendazole, alone or in a combination. The signs that appear in the largest number of the 2,098 reports are "Lethargy", "Vomiting" and "Accidental exposure". A report is not proof that a drug caused a sign.
Reports that name this ingredient rose by 25.5% in the 12 months to June 2026, compared with the 12 months before. Reports for all animal drugs fell by 4.6% in the same periods. The newest months can get more reports in a later update. Reports about dogs are 31.8% of the reports that name this ingredient, and 72.6% of all reports.
Reports in the latest closed quarter
| Species | Jan to Mar 2026 | Oct to Dec 2025 | Jan to Mar 2025 |
|---|---|---|---|
| All species | 70 | 66 | 33 |
| Dog | 6 | 15 | 2 |
| Cat | 44 | 45 | 24 |
| Horse | 0 | 0 | 0 |
| Other or not given | 20 | 6 | 7 |
January to March 2026 is the latest closed quarter in the data.
Drug pages with thiabendazole
A report names a drug by its set of active ingredients. Each set with thiabendazole that has a drug page is in the table, in order of name. The table has 3 sets.
| Active ingredients | Reports, all years | Reports, latest 12 months |
|---|---|---|
| Dexamethasone + Neomycin Sulfate + Thiabendazole | 1,137 | 174 |
| Dexamethasone + Thiabendazole | 904 | 17 |
| Thiabendazole | 56 | 0 |
A report can name more than one set, so the counts of the sets can add to more than the count of the page.
An API dataset query result cannot be used to estimate the risk associated with the product or compare one drug or device product with another.
FDA Center for Veterinary Medicine. Source: Adverse Event Reports for Animal Drugs and Devices
Signs that the reports list
A sign is a coded term from the report. The words in brackets are a plain gloss of the term. The percentage is the share of the 2,098 reports that list the sign. One report can list more than one sign and more than one drug.
The sign that is in the largest number of the reports comes first.
- Lethargy[unusually tired or inactive]11.4%239 reports
- Vomiting8.4%176 reports
- Accidental exposure[exposure that was not intended]8.1%170 reports
- Eye irritation6.5%136 reports
- Unclassifiable adverse event[event that fits no dictionary term]5.4%114 reports
- Anorexia[not eating]5.3%112 reports
- Ataxia[unsteady, uncoordinated movement]4.9%102 reports
- Elevated alanine aminotransferase (ALT)[a liver enzyme above the normal range]4.6%96 reports
- Deafness4.5%95 reports
- Lack of efficacy - NOS[the product did not have the expected effect]4.4%93 reports
- Dispenser, Abnormal[a product quality report, not a sign in an animal]4.1%85 reports
- Not eating4%83 reports
- Pinnal erythema3.2%68 reports
- Vials, Damaged[a product quality report, not a sign in an animal]3.2%67 reports
Show the next 16 signs
- Other abnormal test result NOS[abnormal laboratory result, type not specified]3.1%66 reports
- Behavioural disorder NOS[behaviour change, type not specified]3.1%65 reports
- Eye pain3.1%65 reports
- Weight loss3.1%64 reports
- Diarrhoea[diarrhea]3%63 reports
- Death by euthanasia[the animal was euthanized]2.9%60 reports
- Containers, Abnormal[a product quality report, not a sign in an animal]2.8%59 reports
- Death2.6%54 reports
- Decreased appetite2.6%54 reports
- Elevated total bilirubin[bilirubin above the normal range]2.5%52 reports
- Depression[dull, quiet or withdrawn]2.2%47 reports
- Fever2.2%47 reports
- Vocalisation[crying out or unusual noise]2.1%44 reports
- Containers, Leaking[a product quality report, not a sign in an animal]2%43 reports
- Pruritus[itching]2%43 reports
- Closure, Abnormal[a product quality report, not a sign in an animal]2%42 reports
Reports by species
Reports for each month, Jul 2021 to Jun 2026
No chart: no month has 5 or more reports.
The month is the month in which FDA received the report. Each chart has its own scale. FDA says that a report can take 3 to 6 months to reach the public data. The newest months can get more reports in a later update.
Reports by year
- Dog
- Cat
- Horse
- Other or not given
| Year | Dog | Cat | Horse | Other or not given | All species |
|---|---|---|---|---|---|
| 2026 | 12 | 58 | 0 | 28 | 98 |
| 2025 | 28 | 121 | 0 | 22 | 171 |
| 2024 | 21 | 91 | 0 | 19 | 131 |
| 2023 | 9 | 49 | 0 | 25 | 83 |
| 2022 | 21 | 59 | 0 | 28 | 108 |
| 2021 | 28 | 58 | 0 | 20 | 106 |
| 2020 | 50 | 46 | 0 | 30 | 126 |
| 2019 | 41 | 57 | 0 | 35 | 133 |
| 2018 | 45 | 38 | 0 | 39 | 122 |
| 2017 | 34 | 32 | 0 | 16 | 82 |
| 2016 | 21 | 21 | 0 | 12 | 54 |
| 2015 | 18 | 12 | 0 | 1 | 31 |
| 2014 | 16 | 10 | 0 | 1 | 27 |
| 2013 | 24 | 12 | 0 | 2 | 38 |
| 2012 | 30 | 12 | 0 | 1 | 43 |
| 2011 | 44 | 13 | 0 | 18 | 75 |
| 2010 | 31 | 19 | 0 | 36 | 86 |
| 2009 | 32 | 17 | 0 | 23 | 72 |
| 2008 | 25 | 18 | 0 | 31 | 74 |
| 2007 | 24 | 13 | 0 | 97 | 134 |
| 2006 | 25 | 10 | 0 | 44 | 79 |
| 2005 | 21 | 9 | 0 | 29 | 59 |
| 2004 | 20 | 9 | 0 | 33 | 62 |
| 2003 | 17 | 9 | 0 | 16 | 42 |
| 2002 | 5 | 7 | 0 | 5 | 17 |
| 2001 | 10 | 2 | 0 | 0 | 12 |
| 2000 | 4 | 2 | 0 | 0 | 6 |
| 1999 | 4 | 5 | 0 | 1 | 10 |
| 1998 | 2 | 0 | 0 | 0 | 2 |
| 1997 | 1 | 0 | 0 | 0 | 1 |
| 1996 | 3 | 1 | 0 | 1 | 5 |
| 1992 | 1 | 0 | 0 | 0 | 1 |
| 1991 | 0 | 0 | 0 | 1 | 1 |
| 1990 | 0 | 0 | 0 | 1 | 1 |
| 1989 | 0 | 2 | 0 | 1 | 3 |
| 1987 | 1 | 1 | 0 | 1 | 3 |
2026 has the reports that FDA received through Jun 2026. Download the years (CSV)
What the reports record
Outcome at the time of the report
- Recovered/Normal11.9%250
- Recovered with Sequela[recovered, with a lasting effect]0.4%8
- Ongoing12.3%258
- Died3.1%64
- Euthanized2.6%55
- Outcome Unknown26.7%560
An outcome in a report is not proof that the drug caused it. The person who sends the report gives the outcome. Each share is of the 2,098 reports that name thiabendazole.
Kind of report
- Safety issue74%1,552
- Lack of expected effectiveness2.1%45
- Both safety and lack of expected effectiveness3.7%77
- Manufacturing or product defect20.1%421
- Other0.1%3
Age of the animal
- Under 1 year9.3%195
- 1 to 3 years13.6%285
- 4 to 7 years15.3%322
- 8 to 11 years15.6%328
- 12 years and over16.1%338
- Age not given30%630
Each share of kind and age is of the 2,098 reports that name thiabendazole.
Approved animal drugs with this active ingredient (FDA Green Book)
This section is reference data. It has no report count.
The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand.
Brand names
- Tresaderm Dermatologic
- Equivet-14
- Equizole-B
What the Green Book records give
- Applications with an approval in force
- 3
- Approved species
- Cats, Dogs, Equids
- Dose forms
- Liquid, Liquid (Solution), Solution
- Routes
- Nasogastric, Oral, Topical
- Sale
- RX (prescription)
- Earliest approval date in the records
The species, dose forms and routes are the words of the Green Book records for all the applications together. One product can have fewer. The label of a product gives its approved use.
| Brand name | Active ingredients | Sponsor | Approved species | Application |
|---|---|---|---|---|
| Tresaderm Dermatologic Solution | Dexamethasone, Neomycin Sulfate, Thiabendazole | Boehringer Ingelheim Animal Health USA, Inc. | Dogs, Cats | NADA 042-633 |
| Equivet-14; Equizole-B | Thiabendazole, Trichlorfon | Farnam Companies, Inc. | Horses | NADA 091-067 |
| Thiabendazole, Dexamethasone, Neomycin Sulfate Solution | Dexamethasone, Neomycin Sulfate, Thiabendazole | Dechra Veterinary Products LLC | Dogs, Cats | ANADA 200-565 |
| Thibenzole Sheep & Goat Wormerapproval withdrawn | Thiabendazole | Boehringer Ingelheim Animal Health USA Inc. | Sheep, Goats | NADA 013-022 |
| Equizole Horse Wormerapproval withdrawn | Thiabendazole | Boehringer Ingelheim Animal Health USA Inc. | Horses | NADA 013-407 |
| Thibenzole 20% Swine Premixapproval withdrawn | Thiabendazole | Boehringer Ingelheim Animal Health USA Inc. | Swine | NADA 013-954 |
| Omnizoleapproval withdrawn | Thiabendazole | Boehringer Ingelheim Animal Health USA Inc. | Cattle, Sheep, Goats | NADA 014-350 |
| TBZ Cattle Wormer (Drench)approval withdrawn | Thiabendazole | Boehringer Ingelheim Animal Health USA Inc. | Cattle | NADA 015-123 |
| TBZ 200 Medicated Feed Premixapproval withdrawn | Thiabendazole | Boehringer Ingelheim Animal Health USA Inc. | Cattle, Swine, Sheep, Goats | NADA 015-875 |
| Thibenzole (18 mg)approval withdrawn | Thiabendazole | Boehringer Ingelheim Animal Health USA Inc. | Cattle | NADA 030-103 |
| E-Z-EX Wormer Pelletsapproval withdrawn | Thiabendazole | ADM Animal Nutrition | Cattle, Sheep, Goats | NADA 030-578 |
| Equizoleapproval withdrawn | Thiabendazole | Boehringer Ingelheim Animal Health USA Inc. | Horses, Cattle, Sheep, Goats | NADA 034-114 |
| Thibenzole Pig Wormerapproval withdrawn | Thiabendazole | Boehringer Ingelheim Animal Health USA Inc. | Swine | NADA 035-631 |
| Equizole Aapproval withdrawn | Piperazine Phosphate, Thiabendazole | Boehringer Ingelheim Animal Health USA Inc. | Horses | NADA 037-410 |
| Purina Horse Wormer Medicatedapproval withdrawn | Thiabendazole | Virbac AH, Inc. | Horses | NADA 040-205 |
| E-Z-EX Wormer Mintrate Blockapproval withdrawn | Thiabendazole | ADM Animal Nutrition | Cattle | NADA 042-910 |
| Thibenzole 300 Medicatedapproval withdrawn | Thiabendazole | Boehringer Ingelheim Animal Health USA Inc. | Cattle | NADA 043-141 |
| Equizole Horse Wormer Pelletsapproval withdrawn | Thiabendazole | Boehringer Ingelheim Animal Health USA Inc. | Horses | NADA 044-654 |
| Equizole A Liquidapproval withdrawn | Piperazine Citrate, Thiabendazole | Boehringer Ingelheim Animal Health USA Inc. | Horses | NADA 047-333 |
| TBZ Wormer Paste 50%approval withdrawn | Thiabendazole | Boehringer Ingelheim Animal Health USA Inc. | Cattle | NADA 048-487 |
| TBZ Wormer Paste 43%approval withdrawn | Thiabendazole | Boehringer Ingelheim Animal Health USA Inc. | Cattle | NADA 049-461 |
| Equizole 50% Wormer Paste; Equizole 50% Wormer Paste For Horsesapproval withdrawn | Thiabendazole | Boehringer Ingelheim Animal Health USA Inc. | Horses | NADA 098-689 |
FDA pages for this ingredient
- How to Report Animal Drug and Device Side Effects and Product ProblemsThe FDA page that tells an owner or a veterinarian how to send a report.
- Green Book record of NADA 042-633The FDA record of the application for Tresaderm Dermatologic Solution.
- Green Book record of ANADA 200-565The FDA record of the application for Thiabendazole, Dexamethasone, Neomycin Sulfate Solution.
- Green Book record of NADA 091-067The FDA record of the application for Equivet-14, Equizole-B.
- Animal Drugs @ FDAThe search page of the Green Book, the FDA list of approved animal drugs.
The site checked these addresses on . The links open in a new tab.
Cite this page
Pet Drug Reports. Thiabendazole, all combinations: adverse event reports that FDA received. https://petdrugreports.com/ingredient/thiabendazole/ Source: FDA Center for Veterinary Medicine, openFDA Animal and Veterinary adverse event reports, export of . Reports received through .
Where the data come from
The counts come from the openFDA Animal and Veterinary adverse event files, export of 30 Oct 2026. The files have the reports that the FDA Center for Veterinary Medicine received through 26 Jun 2026. The files mask brand and manufacturer names. The site counts a drug by the active ingredients that each record gives, and gives no count to a brand, an application or a company. Ingredient names and the lists of approved products follow the FDA Green Book of 2 Nov 2026. Ingredient names follow the Green Book, with salts and forms as FDA lists them.
The site does not publish report text, lot numbers or details of a reporter. FDA's record is the authority. See how the site counts reports, the data sources and the corrections page.
Questions about these reports
- Which brand are these reports about?
The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand. The Green Book section of this page lists brand names with this active ingredient.
- Do the reports show that the ingredient caused the signs?
No. A report can name more than one drug, and a drug can have more than one active ingredient. FDA states this about the data.
When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event.
The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources.
FDA Center for Veterinary Medicine. Source: Adverse Event Reports for Animal Drugs and Devices
- How many reports did FDA receive in the latest 12 months?
FDA received 192 reports in the 12 months to June 2026. It received 153 reports in the 12 months before. FDA says that a report can take 3 to 6 months to reach the public data. The newest months can get more reports in a later update.
- What kinds of report are in the count?
Of the 2,098 reports received from January 1987 to June 2026, 74% are about a safety issue only. 5.8% are about a lack of expected effectiveness, alone or with a safety issue. 20.1% are about a defect of the product or its package.